|
Number of patients
|
12
|
12
|
-
|
|
Daily piperaquine (phosphate) dose (mg/kg)
|
18.1 (15.1-24.2)
|
17.6 (13.6-21.7)
|
0.884
|
|
Daily piperaquine (base) dose (mg/kg)
|
10.5 (8.71-13.9)
|
10.2 (7.83-12.5)
|
0.884
|
|
Age (years)
|
21.0 (16.0-43.0)
|
26.0 (18.0-33.0)
|
0.977
|
|
Body weight (kg)
|
53.0 (44.0-81.0)
|
59.0 (50.0-72.0)
|
0.544
|
|
Height (cm)
|
163 (150–174)
|
166 (150–174)
|
0.908
|
|
Estimated gestational age (weeks)
|
-
|
32.0 (15.3–40.1)
|
-
|
|
Parasitemia (parasites/μL)
|
13200 (936–68700)
|
12900 (624–118000)
|
0.488
|
|
Days of fever
|
2.5 (1–6)
|
3 (1–6)
|
0.095
|
|
Fever (°C)
|
38.3 (36.7-40.0)
|
38.2 (36.6-39.9)
|
0.795
|
|
Haemoglobin (g/dL)
|
8.70 (7.60-11.5)
|
9.65 (8.00-12.0)
|
0.099
|
|
Urea (mg/dL)
|
26.0 (24.0-28.0)
|
25.0 (24.0-28.0)
|
0.036
|
|
Serum glutamic pyruvic transaminase (IU/L)
|
5.00 (2.00-10.0)
|
4.50 (2.00-9.00)
|
0.445
|
|
Serum glutamic oxaloacetic transaminase (IU/L)
|
13.5 (2.00-18.0)
|
13.0 (3.00-21.0)
|
0.727
|
